300 related articles for article (PubMed ID: 26254775)
1. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics.
Bogliolo M; Surrallés J
Curr Opin Genet Dev; 2015 Aug; 33():32-40. PubMed ID: 26254775
[TBL] [Abstract][Full Text] [Related]
2. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
[TBL] [Abstract][Full Text] [Related]
4. Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia.
Bogliolo M; Bluteau D; Lespinasse J; Pujol R; Vasquez N; d'Enghien CD; Stoppa-Lyonnet D; Leblanc T; Soulier J; Surrallés J
Genet Med; 2018 Apr; 20(4):458-463. PubMed ID: 28837157
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive molecular study identified 12 complementation groups with 56 novel FANC gene variants in Indian Fanconi anemia subjects.
George M; Solanki A; Chavan N; Rajendran A; Raj R; Mohan S; Nemani S; Kanvinde S; Munirathnam D; Rao S; Radhakrishnan N; Lashkari HP; Ghildhiyal RG; Manglani M; Shanmukhaiah C; Bhat S; Ramesh S; Cherian A; Junagade P; Vundinti BR
Hum Mutat; 2021 Dec; 42(12):1648-1665. PubMed ID: 34585473
[TBL] [Abstract][Full Text] [Related]
6. A possible approach for stem cell gene therapy of Fanconi anemia.
Song L
Curr Gene Ther; 2009 Feb; 9(1):26-32. PubMed ID: 19275569
[TBL] [Abstract][Full Text] [Related]
7. Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia.
Mamrak NE; Shimamura A; Howlett NG
Blood Rev; 2017 May; 31(3):93-99. PubMed ID: 27760710
[TBL] [Abstract][Full Text] [Related]
8. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
[TBL] [Abstract][Full Text] [Related]
9. Multiplexed CRISPR/Cas9-mediated knockout of 19 Fanconi anemia pathway genes in zebrafish revealed their roles in growth, sexual development and fertility.
Ramanagoudr-Bhojappa R; Carrington B; Ramaswami M; Bishop K; Robbins GM; Jones M; Harper U; Frederickson SC; Kimble DC; Sood R; Chandrasekharappa SC
PLoS Genet; 2018 Dec; 14(12):e1007821. PubMed ID: 30540754
[TBL] [Abstract][Full Text] [Related]
10. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
[TBL] [Abstract][Full Text] [Related]
12. Current clinical management of Fanconi anemia.
Smith AR; Wagner JE
Expert Rev Hematol; 2012 Oct; 5(5):513-22. PubMed ID: 23146055
[TBL] [Abstract][Full Text] [Related]
13. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
Hanenberg H; Roellecke K; Wiek C
Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
[TBL] [Abstract][Full Text] [Related]
14. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic research in the crystal chromosome disease Fanconi anemia.
Minguillón J; Surrallés J
Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt A):104-108. PubMed ID: 30389152
[TBL] [Abstract][Full Text] [Related]
16. The Fanconi anaemia/BRCA pathway.
D'Andrea AD; Grompe M
Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
[TBL] [Abstract][Full Text] [Related]
17. Advances in Gene Therapy for Fanconi Anemia.
Río P; Navarro S; Bueren JA
Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
[TBL] [Abstract][Full Text] [Related]
18. Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer?
Martínez-Balsalobre E; Guervilly JH; van Asbeck-van der Wijst J; Pérez-Oliva AB; Lachaud C
Blood Rev; 2023 Jul; 60():101094. PubMed ID: 37142543
[TBL] [Abstract][Full Text] [Related]
19. The Fanconi anemia/BRCA gene network in zebrafish: embryonic expression and comparative genomics.
Titus TA; Yan YL; Wilson C; Starks AM; Frohnmayer JD; Bremiller RA; Cañestro C; Rodriguez-Mari A; He X; Postlethwait JH
Mutat Res; 2009 Jul; 668(1-2):117-32. PubMed ID: 19101574
[TBL] [Abstract][Full Text] [Related]
20. The Fanconi anemia pathway promotes homologous recombination repair in DT40 cell line.
Takata M; Yamamoto K; Matsushita N; Kitao H; Hirano S; Ishiai M
Subcell Biochem; 2006; 40():295-311. PubMed ID: 17623912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]